BIO.News Newsletter

BIO is leading the conversation this week on topics including adult vaccination and Mexico’s looming GM corn ban. (634 words, 3 minutes, 10 seconds)

The end of a busy week brings a new draft BIOSECURE Act—which takes into consideration BIO’s survey findings—and a plan to coordinate and streamline federal regulation of plants, animals, and microorganisms modified through biotechnology. (514 words, 2 minutes, 34 seconds)

Breaking: BIO has released the results of a survey revealing companies’ dependence on Chinese biomanufacturing. Yesterday, a busy day on Capitol Hill featured testimony from a BIO Board member and a reception celebrating the 20th anniversary of Project BioShield. (839 words, 4 minutes, 11 seconds)

A new platform highlights “one of the leading public health threats of our time” through powerful stories, while a report explores the health and occupational hazards of rising temperatures. Today, we’re watching BIO Board member Bill Newell, CEO of Sutro Biopharma, testify on Capitol Hill—stay tuned. (754 words, 3 minutes, 46 seconds)

BIO sets the record straight on accelerated approval—and experts answer YOUR questions about biotech, from how personalized medicine is shaping care to what makes startups attractive to investors. (641 words, 3 minutes, 12 seconds)

A new campaign seeks to #SaveBayhDole—plus, a few more things you need to know today, from D.C. to Texas to Mexico. (642 words, 3 minutes, 12 seconds)

In line with a BIO amicus brief, the California Supreme Court will consider Gilead’s request for summary dismissal of a lawsuit questioning its decisions about drug development. Plus, BIO applauds progress on the Farm Bill. (482 words, 2 minutes, 24 seconds)

Arizona Gov. Hobbs recently vetoed an anti-science bill against animal vaccines, and a group of 26 bipartisan Members of Congress are speaking out against copay accumulator adjustment programs (AAPs). (638 words, 3 minutes, 11 seconds)

A newsy Wednesday: Treasury and the IRS released updated SAF tax credit guidance, a new bill would facilitate value-based drug payments, and a BIO delegation to Paris highlighted Franco-American biotech cooperation. (767 words, 3 minutes, 50 seconds)

BIO announced one of the keynote speakers at the 2024 BIO International Convention: Admiral William McRaven. Plus, Sen. Sanders launched a politically motivated investigation into revolutionary, cost-effective diabetes and obesity medicines—BIO explains what you need to know. (634 words, 3 minutes, 10 seconds)